Churliaev Iu A, Lychev V G, Epifantseva N N, Afanas'ev A G
Anesteziol Reanimatol. 1999 May-Jun(3):35-7.
Detection of clinical and pathogenetic variants of the DIC syndrome for development of its differentiated therapy in multiple-modality treatment of severe craniocerebral injury was the purpose of this study. A total of 170 patients with grave craniocerebral injury were examined. The hemostasis system was studied by the following methods: analysis of platelet hemostasis, general coagulation tests, fibrinolysis evaluation, detection of physiological anticoagulants and markers of intravascular blood coagulation and fibrinolysis. Based on the clinical (intra- and extracranial) symptoms and results of studies of the hemostasis system, 3 clinical pathogenetic variants of the DIC syndrome were distinguished, which should be borne in mine when treating patients with severe craniocerebral injury developing the DIC syndrome.
本研究的目的是检测弥漫性血管内凝血(DIC)综合征的临床和发病机制变异,以便在重度颅脑损伤的多模式治疗中制定其差异化治疗方案。共检查了170例重度颅脑损伤患者。通过以下方法研究止血系统:血小板止血分析、一般凝血试验、纤维蛋白溶解评估、生理性抗凝剂检测以及血管内凝血和纤维蛋白溶解标志物检测。根据临床(颅内和颅外)症状及止血系统研究结果,区分出DIC综合征的3种临床发病机制变异,在治疗发生DIC综合征的重度颅脑损伤患者时应予以考虑。